Trial intelligence / Profile preview

Tranexamic acid and TEG in cesarean delivery

NCT02026297Phase 2Terminated

Sponsor
Brigham and Women's Hospital
Start
Jul 2014
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of tranexamic acid in postpartum hemorrhage (PPH), sponsored by Brigham and Women's Hospital. Primary endpoint: Thromboelastography R-time. Started Jul 2014; status: terminated.

02

Drugs

tranexamic acid
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT02026297.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02026297.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call